Reference Capital SA logo

Reference Capital SA

Europe, Geneve, Switzerland, Genève

Description

Investing in venture capital Funds (US, EU, IL, CN, IN) and direct (digital, sustainability, health).

Investor Profile

Reference Capital SA has made 54 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (20%)
  • Series C (17%)
  • Series Unknown (15%)
  • Series B (11%)
  • Series D (11%)
  • Post Ipo Secondary (6%)
  • Secondary Market (6%)
  • Series G (4%)
  • Post Ipo Equity (4%)
  • Convertible Note (4%)

Country Focus

  • United States (52%)
  • Switzerland (24%)
  • Germany (9%)
  • United Kingdom (7%)
  • Romania (2%)
  • Canada (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Manufacturing
  • Software
  • Information Technology
  • Hardware
  • Pharmaceutical
  • Professional Services
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Reference Capital SA frequently co-invest with?

DEFI Gestion
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 4
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 3
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Sigma Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
VINCI CAPITAL
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Enterprise Partners
North America, California, United States, La Jolla
Co-Investments: 2

Which angels does Reference Capital SA often collaborate with?

RB
North America, Virgin Islands, United States
Shared Deals: 1
AA
North America, California, United States, San Francisco
Shared Deals: 1
David Richter
North America, California, United States, San Francisco
Shared Deals: 1
LL
North America, New York, United States, New York
Shared Deals: 1
IA
North America, California, United States, San Francisco
Shared Deals: 1
RL
Europe, England, United Kingdom, London
Shared Deals: 1
YL
North America, New York, United States, New York
Shared Deals: 1
PA
North America, California, United States, San Francisco
Shared Deals: 1
WT
North America, California, United States, San Francisco
Shared Deals: 1
JZ
North America, California, United States, Campbell
Shared Deals: 1

What are some of recent deals done by Reference Capital SA?

Wayve

London, England, United Kingdom

Wayve is a developer of Embodied AI technology for automated driving.

Artificial Intelligence (AI)Autonomous VehiclesElectric VehicleMachine Learning
Series BJan 17, 2022
Amount Raised: $200,610,840
Kingdom Supercultures

Brooklyn, New York, United States

Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits.

BiotechnologyFood and BeverageLife ScienceManufacturing
Series AOct 5, 2021
Amount Raised: $25,000,000
All Day Kitchens

San Francisco, California, United States

All Day Kitchens operates as a food tech and logistics company.

Food and BeverageFood DeliveryInternet
Series COct 1, 2021
Amount Raised: $65,000,000
T3 Pharmaceuticals

Basel, Basel-Stadt, Switzerland

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

BiotechnologyLife ScienceTherapeutics
Series CJul 22, 2020
Amount Raised: $26,881,027
Monzo

London, England, United Kingdom

Monzo is a digital bank that provides a user-friendly mobile app, innovative features, and a transparent approach to banking.

BankingFinancial ServicesFinTechWealth Management
Series GJun 16, 2020
Amount Raised: $81,792,489
T3 Pharmaceuticals

Basel, Basel-Stadt, Switzerland

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

BiotechnologyLife ScienceTherapeutics
Series BSep 26, 2019
Amount Raised: $12,079,726
SOPHiA GENETICS

Boston, Massachusetts, United States

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Artificial Intelligence (AI)Big DataBioinformaticsBiotechnologyGeneticsHealth CareLife ScienceMedical
Series CDec 16, 2015
Amount Raised: $15,000,000
NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 1, 2012
Neocutis

San Francisco, California, United States

Neocutis is a healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosciences.

BeautyBiotechnologyCosmeticsHealth CareMedicalPersonal Care and Hygiene
Secondary MarketSep 15, 2011
Nexx Systems

Billerica, Massachusetts, United States

NEXX Systems provides processing systems and technologies for wafer-level packaging applications.

HardwareInformation TechnologyManufacturingProfessional Services
Series DOct 27, 2009
Amount Raised: $4,000,000